Hospital-Backed Candidate Wins Missouri GOP Governor Primary Over Two Candidates Who Vowed to Repeal 340B Contract Pharmacy Access Law

Missouri Secretary of State Jay Ashcroft (R) shared a picture on X with Virginia Gov. Glenn Youngkin (R) at the Republican National Convention (RNC) last month praising the governor "for vetoing the 340b legislation that would fund abortions and benefits for illegals." Ashcroft lost his gubernatorial bid Tuesday.
A state hospital-backed candidate won Tuesday’s Missouri Republican gubernatorial primary after defeating a high-profile opponent with dark money ties who [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: AstraZeneca Subpoenas in Arkansas, Mississippi; Minnesota AG’s Defense

Lawsuits challenging 340B contract pharmacy access laws recently heated up in Missouri, Mississippi and Maryland.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Walks Through Hospital Recertification Process Days Before Opening Date

HRSA recently held a webinar for hospitals ahead of their annual 340B recertification period.
The Health Resources and Services Administration (HRSA) held a webinar yesterday to guide hospitals through their annual 340B recertification period, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Private Oncologist Group-Funded Study Highlights 340B Contract Pharmacies’ Links to PBMs

Community Oncology Alliance released a study that tries to connect 340B contract pharmacy relationships to the PBM industry.
More than two-thirds of 340B contract pharmacies are associated with pharmacy benefit managers (PBMs) through either vertical integration or contractual [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two Researchers Call For More 340B Transparency, but JAMA Fails to Disclose Glaring Conflict of Interest

Two researchers authored a recent JAMA opinion piece calling for significant 340B reforms including asking Congress to consider limiting the program to low-income patients.
A recent opinion piece published in JAMA is calling for significant reforms to the 340B program, including more provider transparency, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA to Host Webinar Tomorrow Ahead of 340B Hospital Recertification Window Opening Aug. 12

The annual 340B hospital recertification period will take place between Aug. 12 and Sept. 9.
With the annual 340B hospital recertification period occurring Aug. 12 to Sept. 9, the Health Resources and Services Administration’s (HRSA’s) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Senate Committee Votes to Increase HRSA Funding, Flat Fund OPA and Chides Drug Manufacturers on 340B Restrictions

US Capitol
A Senate Committee recently approved the FY25 Departments of Labor, Health and Human Services, Education and Related Agencies Appropriations Act.
The Senate panel responsible for federal appropriations legislation overwhelmingly passed a bill last week that would increase funding for the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

More Drugmakers Exempt New States from 340B Contract Pharmacy Restrictions

Sanofi was one of three drug manufacturers to recently update its contract pharmacy restrictions in response to new state laws.
Pharmaceutical manufacturers Sanofi, GlaxoSmithKline (GSK) and Viatris are fully or partially exempting additional states from their 340B contract pharmacy restrictions. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Third Drugmaker Sues Kansas Over Its 340B Contract Pharmacy Access Law

Novartis became the third pharmaceutical manufacturer to sue Kansas over its 340B contract pharmacy access law.
Novartis is now the third drug manufacturer to challenge Kansas’ new law prohibiting drug manufacturers from restricting contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Highly Anticipated Bipartisan Senate 340B Overhaul Delayed Ahead of August Recess

The SUSTAIN 340B Act, a bipartisan Senate 340B program overhaul, has been delayed after its planned introduction on Aug. 1.
A long-awaited bipartisan senate bill to overhaul the 340B program will not be introduced prior to the August Congressional recess [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live